IL76366A - 2,6-dialkyl-4-aryl-3,5-diacyl-1,4-dihydropyridine derivatives,processes for their manufacture and pharmaceutical preparations containing them - Google Patents

2,6-dialkyl-4-aryl-3,5-diacyl-1,4-dihydropyridine derivatives,processes for their manufacture and pharmaceutical preparations containing them

Info

Publication number
IL76366A
IL76366A IL76366A IL7636685A IL76366A IL 76366 A IL76366 A IL 76366A IL 76366 A IL76366 A IL 76366A IL 7636685 A IL7636685 A IL 7636685A IL 76366 A IL76366 A IL 76366A
Authority
IL
Israel
Prior art keywords
diacyl
dialkyl
aryl
manufacture
processes
Prior art date
Application number
IL76366A
Other languages
English (en)
Other versions
IL76366A0 (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL76366A0 publication Critical patent/IL76366A0/xx
Publication of IL76366A publication Critical patent/IL76366A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL76366A 1984-09-14 1985-09-11 2,6-dialkyl-4-aryl-3,5-diacyl-1,4-dihydropyridine derivatives,processes for their manufacture and pharmaceutical preparations containing them IL76366A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH438884 1984-09-14

Publications (2)

Publication Number Publication Date
IL76366A0 IL76366A0 (en) 1986-01-31
IL76366A true IL76366A (en) 1989-07-31

Family

ID=4275188

Family Applications (1)

Application Number Title Priority Date Filing Date
IL76366A IL76366A (en) 1984-09-14 1985-09-11 2,6-dialkyl-4-aryl-3,5-diacyl-1,4-dihydropyridine derivatives,processes for their manufacture and pharmaceutical preparations containing them

Country Status (16)

Country Link
US (1) US4853393A (fr)
EP (2) EP0174654A3 (fr)
JP (2) JPS6172751A (fr)
KR (1) KR890000225B1 (fr)
AU (1) AU4744985A (fr)
DD (1) DD237165A5 (fr)
DK (2) DK416985A (fr)
ES (4) ES8802025A1 (fr)
FI (2) FI853477L (fr)
GR (2) GR852216B (fr)
HU (1) HU194871B (fr)
IL (1) IL76366A (fr)
NO (1) NO853609L (fr)
NZ (1) NZ213461A (fr)
PT (2) PT81116B (fr)
ZA (1) ZA857034B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK159420C (da) * 1983-03-09 1991-03-11 Ciba Geigy Ag N-(piperidinyl-alkyl)-carboxamider og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt anvendelsen af forbindelserne til fremstilling af antipsykotiske farmaceutiske praeparater
FI853477L (fi) * 1984-09-14 1986-03-15 Ciba Geigy Ag Foerfarande foer framstaellning av karbonylfoereningar.
JPS61227567A (ja) * 1985-04-01 1986-10-09 Eisai Co Ltd 1,4−ジヒドロピリジン誘導体
DE3682857D1 (en) * 1985-09-13 1992-01-23 Green Cross Corp Dihydropyridinderivate.
EP0222702A3 (fr) * 1985-11-06 1988-01-07 Ciba-Geigy Ag Dérivés carbonyliques basiques
DE3601397A1 (de) * 1986-01-18 1987-07-23 Bayer Ag Substituierte 1,4-dihydropyridin-3-carbonsaeurepiperazide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US4994461A (en) * 1987-03-27 1991-02-19 Byk Gulden Lomberg Chemische Fabrik Gmbh 1,4-dihydropyridine enantiomers
WO1988007531A1 (fr) * 1987-03-27 1988-10-06 Byk Gulden Lomberg Chemische Fabrik Gmbh Nouveaux composes optiquement actifs
DE3724909A1 (de) * 1987-07-28 1989-02-09 Bayer Ag Neue substituierte nitro-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung
US5100892A (en) * 1990-11-13 1992-03-31 Glaxo Inc. Dihydropyridine vasodilator agents
US5258519A (en) * 1990-11-13 1993-11-02 Glaxo Inc. Dihydropyridine vasodilators agents
US5767131A (en) * 1993-04-05 1998-06-16 Synaptic Pharmaceutical Corporation Dihydropyridines and new uses thereof
US6211198B1 (en) 1993-04-05 2001-04-03 Synaptic Pharmaceutical Corporation Dihydropyridines and new uses thereof
CA2361366A1 (fr) 1999-03-26 2000-10-05 Nicholas Kindon Nouveaux composes
AU4688301A (en) * 2000-04-11 2001-10-23 Sankyo Co Stabilized pharmaceutical compositions containing calcium channel blockers
GB0013060D0 (en) * 2000-05-31 2000-07-19 Astrazeneca Ab Chemical compounds
GB0021670D0 (en) * 2000-09-04 2000-10-18 Astrazeneca Ab Chemical compounds
GB0117899D0 (en) * 2001-07-23 2001-09-12 Astrazeneca Ab Chemical compounds
SE0102809D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab Novel compounds
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284634A (en) * 1975-07-02 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, and pharmaceutical method of the same
JPS5283672A (en) * 1976-01-01 1977-07-12 Yamanouchi Pharmaceut Co Ltd Novel 2-amino-1,4-dihydropyridine derivatives
US4307103A (en) * 1978-09-08 1981-12-22 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same
WO1983003249A1 (fr) * 1982-03-17 1983-09-29 Yoshitomi Pharmaceutical Derives de 1,4-dihydropyridine-3,5-dicarboxylate
EP0094159B1 (fr) * 1982-05-10 1990-03-14 Takeda Chemical Industries, Ltd. Dérivés de la dihydropyridine, leur préparation et leur application
WO1983004023A1 (fr) * 1982-05-10 1983-11-24 Takeda Chemical Industries, Ltd. Derives de dihydropyridine
JPS58201765A (ja) * 1982-05-10 1983-11-24 Takeda Chem Ind Ltd ジヒドロピリジン誘導体,その製造法および用途
WO1984002702A1 (fr) * 1983-01-11 1984-07-19 Takeda Chemical Industries Ltd Derives de dihydropyridine
IT1198377B (it) * 1982-06-03 1988-12-21 Pierrel Spa Esteri basici ad attivita' calcioanatagonista,procedimenti per la loro preparazione e relative composizioni farmaceutiche
US4656181A (en) * 1982-11-24 1987-04-07 Cermol S.A. Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
EP0111455A3 (fr) * 1982-12-10 1984-07-25 Ciba-Geigy Ag Lactones non-saturés
US4603135A (en) * 1983-10-17 1986-07-29 Takeda Chemical Industries, Ltd. Substituted piperazinyl alkyl esters of 2-amino-4-aryl-1,4-dihydro-6-alkyl-3,5-pyridinedicarboxylates
FI853477L (fi) * 1984-09-14 1986-03-15 Ciba Geigy Ag Foerfarande foer framstaellning av karbonylfoereningar.

Also Published As

Publication number Publication date
ES546946A0 (es) 1987-02-16
DK416985D0 (da) 1985-09-13
JPS6172752A (ja) 1986-04-14
FI853478A0 (fi) 1985-09-11
ES8800926A1 (es) 1987-12-01
DK416885D0 (da) 1985-09-13
AU4744985A (en) 1986-03-20
ES546945A0 (es) 1986-11-16
US4853393A (en) 1989-08-01
ES554487A0 (es) 1987-07-01
KR890000225B1 (ko) 1989-03-11
FI853478L (fi) 1986-03-15
DK416985A (da) 1986-03-15
IL76366A0 (en) 1986-01-31
KR860002496A (ko) 1986-04-26
DK416885A (da) 1986-03-15
ES8802025A1 (es) 1987-02-16
PT81116A (en) 1985-10-01
GR852215B (fr) 1986-01-14
EP0174654A3 (fr) 1987-07-22
NO853609L (no) 1986-03-17
NZ213461A (en) 1989-07-27
ES554488A0 (es) 1987-12-01
PT81116B (en) 1987-07-15
PT81117B (en) 1987-07-15
FI853477A0 (fi) 1985-09-11
EP0174653A3 (fr) 1987-06-16
ZA857034B (en) 1987-05-27
HU194871B (en) 1988-03-28
FI853477L (fi) 1986-03-15
DD237165A5 (de) 1986-07-02
PT81117A (en) 1985-10-01
ES8701158A1 (es) 1986-11-16
ES8706669A1 (es) 1987-07-01
JPS6172751A (ja) 1986-04-14
EP0174653A2 (fr) 1986-03-19
GR852216B (fr) 1986-01-14
HUT38339A (en) 1986-05-28
EP0174654A2 (fr) 1986-03-19

Similar Documents

Publication Publication Date Title
IL74882A0 (en) Naphthyridine-,quinoline-and benzoxazine-carboxylic acids and derivatives thereof,their manufacture and pharmaceutical compositions containing them
NZ212895A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
EP0161877A3 (en) 1,4-dihydropyridine derivatives, methods for their production and pharmaceutical compositions comprising the same
PT83143A (en) Process for preparing 2-thiomethyl-substituted-1,4-dihydropyridines and pharmaceutical compositions containing them
IL76366A (en) 2,6-dialkyl-4-aryl-3,5-diacyl-1,4-dihydropyridine derivatives,processes for their manufacture and pharmaceutical preparations containing them
IL76405A (en) 1,3-diacyl-2-oxindole derivatives and pharmaceutical compositions containing them
DE3270202D1 (en) 3,5-di-tert-butylstyrene derivatives, processes for their preparations, and pharmaceutical compositions containing them
IL75943A (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
PH24599A (en) Amonoycyllabdanes, pharmaceutical compositions and a process for the preparations thereof
IL85290A0 (en) Substituted 3,4-dihydro-2h-benzopyrans,processes for their preparation and pharmaceutical compositions containing same
ZA853667B (en) New benzazephine derivatives,pharmaceutical compositions containing them and processes for their preparation
ZA862141B (en) Substituted 1,8-naphthyridinones,processes for their preparation and pharmaceutical compositions containing them
HUT44524A (en) Process for producing 1,3-thiazolyl- or 1,3,4-thiadiazolyl- derivatives and pharmaceutical compositions containing them
ZA86301B (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
DE3573428D1 (en) Novel delta4- and delta5- androstene derivatives, processes for their preparation and pharmaceutical compositions containing these derivatives
HK86292A (en) Dihydroorotic acid derivatives,processes for their prepararing and pharmaceutical composition containing them
EP0184841A3 (en) 1,4-dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions containing same
NZ216555A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
GR3001052T3 (en) Novel 16,17-acetalsubstituted pregnane-21-oic acid derivatives, process for the preparation thereof and pharmaceutical preparation containing them
NZ215083A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
DE3661830D1 (en) 2,4-dichlorothiazole derivatives and process for their preparation
IL79542A0 (en) 3,7-disubstituted-3-cephem derivatives,processes for the production thereof and pharmaceutical compositions containing the same
DE3574381D1 (en) Xanthinylmethylthiazolidines, process for their preparation and pharmaceutical compositions containing them
HUT40427A (en) Process for producing 1,3,4-oxa- and -thia-diazol derivatives and pharmaceutical compositions containing them
NZ217282A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions